Mapping variant effects on anti-tumor hallmarks of primary human T cells with base-editing screens-Reference-Cited by-同舟云学术

Mapping variant effects on anti-tumor hallmarks of primary human T cells with base-editing screens

Published:2024-05-23 Issue: Volume: Page:
ISSN:1087-0156
Container-title:Nature Biotechnology
language:en
Short-container-title:Nat Biotechnol

Author:

Walsh Zachary H.,Shah Parin,Kothapalli Neeharika,Shah Shivem B.^ORCID,Nikolenyi Gergo^ORCID,Brodtman D. Zack^ORCID,Leuzzi Giuseppe^ORCID,Rogava Meri,Mu Michael,Ho Patricia^ORCID,Abuzaid Sinan^ORCID,Vasan Neil^ORCID,AlQuraishi Mohammed^ORCID,Milner Joshua D.^ORCID,Ciccia Alberto^ORCID,Melms Johannes C.^ORCID,Izar Benjamin^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41587-024-02235-x.pdf

Reference73 articles.

1. Finck, A. V., Blanchard, T., Roselle, C. P., Golinelli, G. & June, C. H. Engineered cellular immunotherapies in cancer and beyond. Nat. Med. 28, 678–689 (2022).

2. Forget, M.-A. et al. Prospective analysis of adoptive TIL therapy in patients with metastatic melanoma: response, impact of anti-CTLA4, and biomarkers to predict clinical outcome. Clin. Cancer Res. 24, 4416–4428 (2018).

3. Rosenberg, S. A. & Restifo, N. P. Adoptive cell transfer as personalized immunotherapy for human cancer. Science 348, 62–68 (2015).

4. Ruella, M., Korell, F., Porazzi, P. & Maus, M. V. Mechanisms of resistance to chimeric antigen receptor-T cells in haematological malignancies. Nat. Rev. Drug Discov. 22, 976–995 (2023).

5. Ho, P. et al. The CD58–CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity. Cancer Cell 41, 1207–1221 (2023).

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mapping variant effects on anti-tumor hallmarks of primary human T cells with base-editing screens;Nature Biotechnology;2024-05-23